Masayoshi Tanaka

Masayoshi Tanaka

Auto-generated profile, based on publicly available information

Masayoshi Tanaka

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2025 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
MTMasayoshi Tanaka
Masayoshi Tanaka
SIShin Ishikane
Shin Ishikane
DBDong Bin Back
Dong Bin Back
ELEster Licastro
Ester Licastro
FZFang Zhang
Fang Zhang
Kazuhide HayakawaKazuhide Hayakawa
Kazuhide Hayakawa
Therapeutic administration of mitochondria has been increasingly explored. However, how these administered mitochondria impact immune response remains to be fully addressed. In this proof-of-concept study, we show that extracellularly added mitochondria to cultured peritoneal macrophages increase phagocytosis and recycling exocytosis that amplifies neuroplasticity mediated by recycled mitochondria transfer. Macrophage activation markers such as Nos2 , Arg1 , and Cd163 were unchanged at 3 h post-treatment with mitochondria, but whole mitochondria or delivery of mRNAs extracted from whole mitochondria appeared to increase SQSTM1 protein and activate Nrf2-mediated phagocytosis in macrophages, whereas mitochondria treatment did not change the ability of phagocytosis in cultured microglia or astrocytes. Notably, the once engulfed mitochondria in macrophages appear to be released via Rab27a-mediated recycling pathway that were favorably incorporated in mechanically damaged neurons compared with healthy neurons, resulting in accelerating neurite extension in damaged neurons in a direct co-culture model. Altogether, these findings uncover unappreciated mechanisms that mitochondria-treated macrophages upregulate phagocytosis and recycling exocytosis, implicating that engineering mitochondria delivery to macrophages is a new therapeutic intervention to promote neurorecovery in CNS disorders.

16 April 2025 in Brain Research
Verified
Journal Article
Closed access
JPJi Hyun Park
Ji Hyun Park
DBDong Bin Back
Dong Bin Back
SGShuzhen Guo
Shuzhen Guo
MTMasayoshi Tanaka
Masayoshi Tanaka
HTHajime Takase
Hajime Takase
ELEng Lo
Eng Lo

Verified
Journal Article
Open access
PDF file
YKYuto Kubota
Yuto Kubota
ESEiji Shigetomi
Eiji Shigetomi
KSKozo Saito
Kozo Saito
YSYouichi Shinozaki
Youichi Shinozaki
KKKenji Kobayashi
Kenji Kobayashi
Schuichi KoizumiSchuichi Koizumi
Schuichi Koizumi
Alexander disease (AxD) is an intractable neurodegenerative disease caused by mutations in glial fibrillary acidic protein (GFAP), which is predominantly expressed in astrocytes. Thus, AxD is a primary astrocyte disease. However, it remains unclear how GFAP mutations affect astrocytes and cause AxD pathology. Three features are characteristic of AxD astrocytes in vivo: (1) Rosenthal fibers (RFs), the hallmark of AxD; (2) aberrant Ca2+ signals (AxCa); and (3) upregulation of disease-associated genes (AxGen). We established a primary culture system for astrocytes from an AxD transgenic mouse model, and used it to analyze the above features of AxD pathogenesis in astrocytes in vitro. We observed the formation of RFs in AxD primary cultures. The abundance of RFs was greater in AxD-transgene-homozygous compared with -hemizygous astrocytes, indicating a gene dosage effect, and this abundance increased with time in culture, indicating a developmental process effect. However, cultured AxD astrocytes did not exhibit changes in either AxCa or AxGen. We therefore conclude that RFs in astrocytes form via a cell-autonomous mechanism, whereas AxCa and AxGen are likely to occur via a non-cell-autonomous mechanism through interactions with other cells, such as neurons, microglia, and vascular cells. Although primary cultured AxD astrocytes are suitable for elucidating the mechanisms of RFs formation and for intervention studies, it should be noted that they cannot reflect the pathophysiology of non-cell-autonomous events in astrocytes.